Company information:
Noxsudor Therapeutics Limited (No: 09485187)
Address: 20-22 WENLOCK ROAD, LONDON, ENGLAND, N1 7GU, ENGLAND
Status: Active
Incorporated: 03-Dec-2015
Accounts Next Due: 30-Dec-2020
Next Confirmation Statement Due: 26-Mar-2021
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: ANNALISA LISA MARY JENKINS ( DOB: Jun-1965 From: Dec-2018 )
Current Director: ANNA LISA MARY JENKINS ( DOB: Jun-1965 From: Dec-2018 )
Current Director: MARIA KONOVALOVA ( DOB: Jun-1993 From: Dec-2018 )
Current Director: DAVID JOHN MACFARLANE ( DOB: Apr-1946 From: Apr-2015 )
Current Director: TIMOTHY MICHAEL STEEL ( DOB: Apr-1952 From: Apr-2015 )
Current Secretary: MELANIE CLARE HALL ( From: Jul-2019 )
Resigned Director: HERBERT OAKES ( From: Mar-2015 To: Jan-2019 )
Company Accounts Summary (£)
| Item | 2016-03 | 2017-03 | 2018-03 | 2019-03 | Chart |
|---|---|---|---|---|---|
| Current assets | 51,990 | 9,942 | 19,851 | 47,520 | 51990.0,9942.0,19851.0,47520.0 |
| Current assets / Debtors | 27,119 | 27119.0,0.0,0.0,0.0 | |||
| Current assets / Cash at bank and on hand | 24,871 | 9,942 | 24871.0,9942.0,0.0,0.0 | ||
| Net current assets (liabilities) | 51,330 | 9,447 | 20,851 | 47,520 | 51330.0,9447.0,20851.0,47520.0 |
| Net assets (liabilities) | 51,330 | 9,447 | 20,851 | 47,520 | 51330.0,9447.0,20851.0,47520.0 |
| Equity / share capital and reserves | 51,330 | 9,447 | 20,851 | 47,520 | 51330.0,9447.0,20851.0,47520.0 |